Clinical Trial Update: A Study of BIIB022 in Combination With Paclitaxel and Carboplatin in Subjects With Non-Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 1 study evaluating BIIB022 in combination with paclitaxel and carboplatin in patients with non-smal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• BIIB022
• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Biogen | Conditions: Non-Small Cell Lung Cancer | Phase 1 | Status: COMPLETED